June 22, 2016
(Nature) – The first and only published papers to describe genome modification in human embryos have come from Chinese laboratories. For some, this is another signal of China’s successful transformation from a closed society focused on farming and the manufacturing of commodities to a world leader in innovation. For others, these studies are the latest in a list of feats reported over the past decade that reflect the country’s lax regulation or cultural indifference to fundamental ethical tensions. In our view, fears that China’s scientific ambitions are overwhelming its ability to exercise appropriate caution in the life sciences — particularly in research involving human embryos — are overblown.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.